Late-breaking clinical study results

presented at DIGESTIVE DISEASE WEEK (DDW) 2016

 

A new blood test for the detection of Colorectal Cancer (CRC)
Measurement of Natural Killer Cell Activity (NKA) in patients undergoing colonoscopy.

 

The results of this study will be presented for the first time at DDW 2016, May 21-24, 2016.

If you are attending the conference, please visit Dr. Gilles Jobin, Chief of Gastroenterology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, at poster #Tu2088 during the Clinical Science Late-breaking poster session on Tuesday, May 24, 2016, starting at 9:30 a.m. in Hall C-SDCC.

If you don't have a chance to see his poster, additional study details are available at https://clinicaltrials.gov/ct2/show/NCT02291198. For more information on measurement of NK cell activity, please visit www.atgencanada.com.

If you are unable to attend DDW, the abstract has been published in the April 2016 supplement of Gastroenterology on page S-1270.

 

ATGen Canada did not provide financial support for this scientific session and did not influence the content in any way.
However, research presented within this scientific session has been supported by ATGen Canada.

 

For Media inquiries please contact Gaétan Huneault, President at 1-855-561-4681, extension 201.